Markets

Market Nav

NINE MONTHS RESULTS

Accretion Pharmaceuticals Ltd.
( in Crs.)

ParticularsDec 24
Net Sales/Income from operations35.67
Total Income From Operations35.67
  
EXPENDITURE 
Consumption of Raw Materials26.69
Increase/Decrease in Stocks-3.98
Employees Cost2.30
Depreciation0.57
Other Expenses1.92
Total Expenses27.50
  
P/L Before Other Inc. , Int., Excpt. Items & Tax8.17
Other Income0.08
P/L Before Interest, Excpt. Items & Tax8.25
Interest1.06
P/L Before Exceptional Items & Tax7.19
P/L Before Tax7.19
Tax1.95
P/L After Tax from Ordinary Activities5.24
Net Profit/Loss For the Period5.24
  
Equity Share Capital8.17
EPS Before Extra Ordinary * 
Basic EPS (Rs.)8.74
Diluted EPS (Rs.)8.74
EPS After Extra Ordinary * 
Basic EPS (Rs.) 8.74
Diluted EPS (Rs.) 8.74
  
PBITOE Margin (%)22.90
PBTE Margin (%)20.15
PBT Margin (%)20.15
PAT Margin (%)14.67
ParticularsDec 24
Net Sales/Income from operations35.67
Total Income From Operations35.67
  
EXPENDITURE 
Consumption of Raw Materials26.69
Increase/Decrease in Stocks-3.98
Employees Cost2.30
Depreciation0.57
Other Expenses1.92
Total Expenses27.50
P/L Before Other Inc. , Int., Excpt. Items & Tax8.17
Other Income0.08
P/L Before Interest, Excpt. Items & Tax8.25
Interest1.06
P/L Before Exceptional Items & Tax7.19
P/L Before Tax7.19
Tax1.95
P/L After Tax from Ordinary Activities5.24
Net Profit/Loss For the Period5.24
Equity Share Capital8.17
EPS Before Extra Ordinary * 
Basic EPS (Rs.)8.74
Diluted EPS (Rs.)8.74
EPS After Extra Ordinary * 
Basic EPS (Rs.) 8.74
Diluted EPS (Rs.) 8.74
PBITOE Margin (%)22.90
PBTE Margin (%)20.15
PBT Margin (%)20.15
PAT Margin (%)14.67